$3.9 Million NIH Grant to Fuel U-M Effort to Develop First Targeted Therapy for Fatal Childhood Brain Disorder
October 06, 2026
October 06, 2026
ANN ARBOR, Michigan, Oct. 6 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
$3.9 million NIH grant to fuel U-M effort to develop first targeted therapy for fatal childhood brain disorder
October 5, 2026
For children with CLN3 Batten disease, the first symptom is often vision loss. What follows is relentless neurological decline and currently there is no effective treatmen . . .
* * *
$3.9 million NIH grant to fuel U-M effort to develop first targeted therapy for fatal childhood brain disorder
October 5, 2026
For children with CLN3 Batten disease, the first symptom is often vision loss. What follows is relentless neurological decline and currently there is no effective treatmen . . .